Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
300705.SZ
BUYREMOVEHunan Jiudian Pharmaceutical Co., Ltd. · Healthcare · China · $869M · Avg Vol: $8M/d
Hunan Jiudian is a high-quality pharmaceutical company specializing in transdermal patches, but it does not operate as a global CDMO and lacks direct alignment with our macro themes.
COMPANY DESCRIPTION
Hunan Jiudian Pharmaceutical Co., Ltd. develops and manufactures pharmaceutical formulations, active ingredients (APIs), and excipients, with a market-leading specialization in transdermal drug delivery systems like gel patches. The company's competitive moat is its vertically integrated "API + formulation" business model and proprietary formulation technologies that yield high-barrier topical preparations. It is a fast-growing specialty pharmaceutical leader in China's pain management and transdermal patch markets.
FINANCIAL SUMMARY
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 344M | 398M | 433M | 460M | 10.2% |
| EPS | 0.09 | 0.11 | 0.16 | 0.14 | 17.9% |
| Shares | 480M | 483M | 496M | 500M | +4.2% |
| Debt | 47M | 58M | 45M | 78M | 18.6% |
| Equity | 229M | 292M | 373M | 393M | 19.6% |
| Op CF | 40M | 64M | 110M | 96M | 34.0% |
| Inv CF | -64M | -63M | -96M | -94M | — |
| Fin CF | 18M | 11M | -11M | 722,752 | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300705.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 300705.SZ | Hunan Jiudian Pharmaceutical Co., Ltd.(you) | $869M | 70 | BUY |
| 603439.SS | Guizhou Sanli Pharmaceutical Co.,Ltd | $984M | 70 | BUY |
| 300039.SZ | Shanghai Kaibao Pharmaceutical CO.,Ltd | $822M | 68 | BUY |
| 002437.SZ | HARBIN GLORIA PHARMACEUTICALS Co., LTD | $975M | 73 | BUY |
| 688566.SS | Jiangsu Jibeier Pharmaceutical Co., Ltd. | $741M | 65 | BUY |
| 000597.SZ | Northeast Pharmaceutical Group Co., Ltd. | $983M | 64 | HOLD |
| 600195.SS | China Animal Husbandry Industry Co., Ltd. | $996M | 64 | HOLD |
| 603207.SS | Shanghai Xiao Fang Pharmaceutical Co.,Ltd. | $556M | 70 | BUY |
| 600557.SS | Jiangsu Kanion Pharmaceutical Co.,Ltd. | $1.1B | 65 | HOLD |
| 002550.SZ | Changzhou Qianhong Biopharma CO.,LTD | $1.2B | 66 | BUY |
Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%